Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA to weigh easing limits on unproven peptides New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn